Curso clínico de la COVID-19 en pacientes con hipertensión arterial pulmonar
Authors:
- Jorge NucheJNJorge Nuche
- Carmen Pérez-OlivaresCPCarmen Pérez-Olivares
- Teresa Segura de la CalTCTeresa Segura de la Cal
- Carmen Jiménez López-GuarchCLCarmen Jiménez López-Guarch
- Fernando Arribas YnsaurriagaFYFernando Arribas Ynsaurriaga
- Pilar Escribano SubíasPSPilar Escribano Subías
- 1 September 2020
- journal article
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 73 (9) , 775-778
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Potential Effects of Coronaviruses on the Cardiovascular SystemJAMA Cardiology, 2020
- Management of COVID-19 Respiratory DistressJAMA, 2020
- Current Pharmacological Approach to ARDS: The Place of BosentanThe Eurasian Journal of Medicine, 2020
- Primary cardiac hospitalizations in pulmonary arterial hypertension: Trends and outcomes from 2001 to 2014Respiratory Medicine, 2020
- A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertensionEuropean Respiratory Journal, 2018
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005